News By Tag
News By Location
Follow on Google News
2016 Global Health Repurposing Awards Raises Funds, Honors Leaders Creating Patient Impact
Cures Within Reach President Dr. Bruce Bloom makes a call-to-action for more clinicians and other healthcare provider involvement in repurposing research on the CureAccelerator platform™
"We have never been at a better time for orphan and rare diseases because of the innovations taking place today involving new and existing drugs, " said Mark J. Alles, CEO of Celgene, presenting sponsor of the Global Health Repurposing Awards. "Medicine allows us to bring together all of the tools we have to deal with these issues and create lifesaving value for patients."
Emceed by WGN's Micah Materre, more than $150,000 was raised from sponsors, attendees, live auction, paddle raise and silent auction to support the mission and programs of Cures Within Reach (www.cureswithinreach.org)
"We know that 20 percent of all prescriptions in the U.S. are written off-label, which means the drug is being prescribed for a repurposing use," said Dr. Bloom. "Right now there's nowhere for physicians to quickly and easily share what's working in the world of repurposing, so we are expanding our CureAccelerator platform (www.CureAccelerator.org)
Three outstanding leaders were also recognized for creating patient impact through scientific, business and philanthropic achievements. This year's featured awardees were:
• --- Dr. Jerome B. Zeldis, Chief Medical Officer of Celgene Corporation & CEO of Celgene Global Health, received the Patient Impact Legacy Award in honor of his work to repurpose Celgene therapies for diseases in the developing world.
• --- Nick Sireau, Chairman of the AKU Society, with Professor Lakshminarayan Ranganath, received the Patient Impact Philanthropic Award in honor of their fundraising to support the clinical trial repurposing nitisinone for Alkaptonuria.
• --- Marty St. Clair, Viiv Healthcare, received the Janet Davidson Rowley Patient Impact Research Award in honor of her discovery repositioning AZT for HIV.
The 2017 Global Health Repurposing Awards, being planned for June 27, 2017, will be dedicated to repurposing in rare diseases. We look forward to leadership and participation from our partners at the National Institutes of Health, as well as industry and rare disease organizations from around the globe.
Sponsors of the Global Health Repurposing Awards included Celgene (Premier Sponsor), Takeda Pharmaceuticals, (Diamond Sponsor), Horizon Pharma plc. (Gold Sponsor), PwC (Gold Sponsor), Beecken Petty O'Keefe & Company (Gold Sponsor), HuLow Medical LLC (Silver Sponsor), Mavens (Silver Sponsor), Rediscovery Life Sciences (Silver Sponsor), Camargo Pharmaceutical Services (Bronze Sponsor), Millco Investments (Bronze Sponsor), Aptinyx (Bronze Sponsor), Steve Braun (Bronze Sponsor), Golan & Christie (Bronze Sponsor) and Rachel & David Grund (Bronze Sponsor).
The 2016 event committee included Kristina Allikmets, Takeda Pharmaceuticals;
ABOUT CURES WITHIN REACH
Cures Within Reach (http://www.cureswithinreach.org) works to catalyze repurposing research to quickly and affordably improve patient lives. We accomplish this through collaborations that connect researchers and funding, by facilitating crowd sourcing and community, and by identifying alternative financing models and incentives.
Cures Within Reach's repurposing research projects have generated 13 "new" treatments making an impact through off-label use in clinical practice or through a commercialization track.
Cures Within Reach built CureAccelerator (http://www.cureaccelerator.org) to provide a global collaboration space and market for repurposing research that can deliver effective solutions to unsolved diseases. The CureAccelerator platform was built with a grant from the Robert Wood Johnson Foundation, to explore whether drugs, devices and nutriceuticals approved for one or more human diseases can be repurposed to create "new" treatments in other diseases. CureAccelerator has almost 1000 users who have proposed over 100 projects, of which more than a dozen are already funded and moving towards patient impact.
Visit us at www.cureswithinreach.org or follow us via Twitter.com/
Director of Media Relations
Account Email Address Account Phone Number Disclaimer Report Abuse